Proteopedia

Tositumomab

Revision as of 09:36, 6 December 2010 by David Canner (talk | contribs) (New page: ===Pharmacokinetics=== {| class="wikitable" border="1" width="52%" style="text-align:center" |- ! colspan="12" align="center"| Anti-CD20 Monoclonal Antibody [[Pharmaceutical_Drugs#Pharmac...)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

PharmacokineticsPharmacokinetics

Anti-CD20 Monoclonal Antibody Pharmacokinetics
Parameter Tositumomab Ofatumumab Rituximab Ibritumomab
Tmax (hr) Tositumomab Ofatumumab Rituximab Ibritumomab
Cmax (ng/ml) Tositumomab Ofatumumab Rituximab Ibritumomab
Bioavailability (%) Tositumomab Ofatumumab Rituximab Ibritumomab
Protein Binding (%) Tositumomab Ofatumumab Rituximab Ibritumomab
T1/2 (hr) Tositumomab Ofatumumab Rituximab Ibritumomab
AUC (ng/ml/hr) Tositumomab Ofatumumab Rituximab Ibritumomab
Clearance (L/h) Tositumomab Ofatumumab Rituximab Ibritumomab
Tositumomab Ofatumumab Rituximab Ibritumomab
Tositumomab Ofatumumab Rituximab Ibritumomab

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

David Canner
Retrieved from "https://proteopedia.openfox.io/wiki/index.php?title=Tositumomab&oldid=1152740"